1
/
of
1
Elabscience
SKU:PKSM040324
Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag)
Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag)
Regular price
$486.00 USD
Regular price
Sale price
$486.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag), a cutting-edge product designed to revolutionize the field of bone biology research. This meticulously engineered protein, derived from mouse sources, offers an unparalleled level of purity and functionality.
The Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is a fusion protein that combines the osteoprotegerin (OPG) domain with the Fc region of immunoglobulin G (IgG). This fusion construct not only enhances the stability and solubility of the protein but also facilitates its purification and detection.
With its Fc tag, this recombinant protein can be easily immobilized onto various surfaces, enabling a wide range of applications in both in vitro and in vivo studies. Its exceptional binding affinity to receptor activator of nuclear factor kappa-B ligand (RANKL) makes it an invaluable tool for investigating the intricate mechanisms underlying bone remodeling and osteoclastogenesis.
The Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is produced using state-of-the-art recombinant DNA technology, ensuring a high level of consistency and reproducibility. Each batch undergoes rigorous quality control measures to guarantee its purity, integrity, and biological activity.
Researchers and scientists can now confidently explore the intricate interplay between OPG and RANKL, shedding light on the pathogenesis of bone-related disorders such as osteoporosis, rheumatoid arthritis, and bone metastasis. This protein holds immense potential for the development of novel therapeutic strategies and the identification of new drug targets.
In summary, the Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is a game-changing product that empowers researchers with a powerful tool to unravel the complexities of bone biology. Its exceptional purity, stability, and functionality make it an indispensable asset in advancing our understanding of bone-related diseases and paving the way for innovative therapeutic interventions.
The Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is a fusion protein that combines the osteoprotegerin (OPG) domain with the Fc region of immunoglobulin G (IgG). This fusion construct not only enhances the stability and solubility of the protein but also facilitates its purification and detection.
With its Fc tag, this recombinant protein can be easily immobilized onto various surfaces, enabling a wide range of applications in both in vitro and in vivo studies. Its exceptional binding affinity to receptor activator of nuclear factor kappa-B ligand (RANKL) makes it an invaluable tool for investigating the intricate mechanisms underlying bone remodeling and osteoclastogenesis.
The Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is produced using state-of-the-art recombinant DNA technology, ensuring a high level of consistency and reproducibility. Each batch undergoes rigorous quality control measures to guarantee its purity, integrity, and biological activity.
Researchers and scientists can now confidently explore the intricate interplay between OPG and RANKL, shedding light on the pathogenesis of bone-related disorders such as osteoporosis, rheumatoid arthritis, and bone metastasis. This protein holds immense potential for the development of novel therapeutic strategies and the identification of new drug targets.
In summary, the Recombinant Mouse Osteoprotegerin/TNFRSF11B Protein (Fc Tag) is a game-changing product that empowers researchers with a powerful tool to unravel the complexities of bone biology. Its exceptional purity, stability, and functionality make it an indispensable asset in advancing our understanding of bone-related diseases and paving the way for innovative therapeutic interventions.
Share
